The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
分析師格局：對愛奧尼斯製藥的8種看法
Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，有8位分析師提供了愛奧尼斯製藥公司（納斯達克股票代碼：IONS）的評級，顯示了看漲和看跌的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $67.12, a high estimate of $82.00, and a low estimate of $60.00. This current average has decreased by 3.29% from the previous average price target of $69.40.
分析師12個月目標股價的見解已經公佈，平均目標股價爲67.12美元，最高估計爲82.00美元，低估值爲60.00美元。目前的平均價格較之前的平均目標價69.40美元下降了3.29％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
The analysis of recent analyst actions sheds light on the perception of Ionis...
對分析師近期行爲的分析揭示...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。